To determine whether tumor levels of CCT2 correlated with prognostic markers for breast cancer, we examined the MBC cohort (Table 1) for levels of CCT2 in the tumor tissue, tumor lineage markers, time of diagnosis, and the number of CTCs enumerated using standard epithelial markers. This evidence concerns the gene CCT2 and breast carcinoma.